After Receiving a Warning Letter From the US Food and Drug Administration, Cipla’s Stock Price Drops More Than 7%, Making It the Top Loser in the Nifty 50
Cipla’s stock dropped more than 7% on Thursday after the US FDA issued a warning notice to the company’s Pithampur plant.
The stock failed to hold above the swing high of the August month and may underperform in the near term.
Cipla‘s share price today started at an intraday high of 1,272.95 per share on the BSE. Cipla has emerged as the Nifty 50’s top laggard thus far today.